Avyxa Pharma, LLC
A DOL Labor Condition Application record spanning FY2024–2025. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 4
- DOL-certified
- 100%
- Median offered wage
- $148,250
Parsippany, NJ NAICS: 325412
Avyxa Pharma, LLC, by the LCA numbers
U.S. Department of Labor's OFLC discloses 4 Labor Condition Application filings naming Avyxa Pharma, LLC from FY2024 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
USCIS adjudication record for Avyxa Pharma, LLC
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 1 H-1B petitions naming Avyxa Pharma, LLC through FY2024, and approved nearly every one of them: 100% approved (1 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Avyxa Pharma, LLC is listed in 4 DOL LCA filings, more filings than 73% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $148,250. This is not a USCIS approval, hiring, or sponsorship ranking.
- 4
- DOL LCA filings, FY2024–FY2025
- 100%
- DOL-certified
- $148,250
- median offered wage
- Top 27%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2024–FY2025). Based in Parsippany, NJ.
Avyxa Pharma, LLC vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
4 40444th of 122824 higher than 82,380 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2024–FY2025
LCA filing shape · Avyxa Pharma, LLC
Derived from this employer's disclosed LCAs on file (FY2024–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $115,000–$205,000 .
Title concentration
- Commercial Analytics Manager 2 · 50% · $122,500
- Vice President Strategic Operations and Regulatory Affairs 1 · 25% · $205,000
- Commercial Analytics Sr. Manager 1 · 25% · $143,000
Worksite counties
- CUMBERLAND, PA 2 · 66.7%
- MORRIS, NJ 1 · 33.3%
Thin filer, multi-state worksites
Only 4 LCAs, but worksites already span 3 states (PA, CA). HQ Parsippany, NJ · DOL cert 100%.
Geographic Distribution
Where Avyxa Pharma, LLC places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by Avyxa Pharma, LLC
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Commercial Analytics Manager | San Francisco, CA | $115,000 | Certified | FY2025 |
| Commercial Analytics Sr. Manager | Mechanicsburg, PA | $143,000 | Certified | FY2025 |
| Commercial Analytics Manager | Mechanicsburg, PA | $130,000 | Certified - Withdrawn | FY2025 |
| Vice President Strategic Operations and Regulatory Affairs | Parsippany, NJ | $205,000 | Certified | FY2024 |
Nationwide peers near Avyxa Pharma, LLC's 4-LCA band
Cross-state DOL neighbors for Avyxa Pharma, LLC - LCA filing-count and offered-wage axes, outside NJ.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($148,250 here).
Disclaimer: Informational only, not professional advice.
Read with Avyxa Pharma, LLC
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs Avyxa Pharma, LLC); CERT-LOCK · WAGE-PREMIUM vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs Avyxa Pharma, LLC); CERT-LOCK · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs Avyxa Pharma, LLC); CERT-SOFT · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs Avyxa Pharma, LLC); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Avyxa Pharma, LLC's TRACE-BOOK.
Open the NJ state board after the ABS peers. Avyxa Pharma, LLC stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Avyxa Pharma, LLC's WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Avyxa Pharma, LLC to compare filing volume and offered wages, not USCIS outcomes.
- Avyxa Pharma, LLC filed 4 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 73% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NJ rank on LCA filing volume this vintage. NJ filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.